FOLLOWUS
1. The First Affiliated Hospital of Medical College of Zhejiang University,Hangzhou,China
2. Zhejiang Provincial Hospital of Traditional Chinese Medicine,Hangzhou,China
3. The First People’s Hospital of Hangzhou,Hangzhou,China
纸质出版日期:2016,
网络出版日期:2015-6-24,
Scan for full text
Shi, Hf., Xu, F., Shi, Y. et al. Effect of ear-acupoint pressing and Ear Apex (HX6,7) bloodletting on haemorheology in chloasma patients with Gan depression pattern., Chin. J. Integr. Med. 22, 42–48 (2016). https://doi.org/10.1007/s11655-015-2109-2
Hong-fei Shi, Fu Xu, Yan Shi, et al. Effect of ear-acupoint pressing and Ear Apex (HX6,7) bloodletting on haemorheology in chloasma patients with Gan depression pattern[J]. Chinese Journal of Integrative Medicine, 2016,22(1):42-48.
Shi, Hf., Xu, F., Shi, Y. et al. Effect of ear-acupoint pressing and Ear Apex (HX6,7) bloodletting on haemorheology in chloasma patients with Gan depression pattern., Chin. J. Integr. Med. 22, 42–48 (2016). https://doi.org/10.1007/s11655-015-2109-2 DOI:
Hong-fei Shi, Fu Xu, Yan Shi, et al. Effect of ear-acupoint pressing and Ear Apex (HX6,7) bloodletting on haemorheology in chloasma patients with Gan depression pattern[J]. Chinese Journal of Integrative Medicine, 2016,22(1):42-48. DOI: 10.1007/s11655-015-2109-2.
To explore the therapeutical effect of ear-acupoint pressing combined with Ear Apex (HX6
7) bloodletting on haemorheology in chloasma patients with Gan (Liver) depression pattern. A total of 180 chloasma patients were randomly assigned to three groups
60 cases in each. Patients in the earacupuncture (EA) group were treated with ear-acupoint pressing combined with Ear Apex (HX6
7) bloodletting; vitamins C and E were put into practice in the Western medicine (WM) group together with 0.025% tretinoin cream for local external application; patients in the placebo group were treated with urea-cream by external use
while 30 healthy volunteers were in the control group. After a treatment course of 2 months
the changes of haemorheology
injury skin area
colour score and symptom score before and after the treatment were observed. There was no significant difference on whole blood reduced viscosity (high shear
medium shear
and low shear)
erythrocyte aggregation index
hematocrit
plasma viscosity among the four groups (F =2.65
P>0.05). Compared with those before treatment
the whole blood viscosity (high shear) and whole blood reduced viscosity (high shear) after treatment in the EA group
the WM group and the placebo group were with no statistical significance (P>0.05). The injury skin area and colour score after treatment were significantly lower than those before treatment in the EA group and the WM group (P<0.05)
while there was no significant difference in placebo group (P>0.05). Clinical symptoms of the EA group were obviously improved after the 2-month treatment
which was significantly different compared with those before treatment (P<0.05)
there was significant difference compared with those of WM group and placebo group (P<0.05). There was no significant difference on haemorheology index between healthy people and chloasma patients without angionosis
cerebrovascular disease
hematopathy
metabolic disease or any other organic disease. Ear-acupoint pressing combined with Ear Apex (HX6
7) bloodletting can effectively improve concurrent symptoms
lighten chloasma and lower chloasma area in patients accompanied by Gan depression.
To explore the therapeutical effect of ear-acupoint pressing combined with Ear Apex (HX6
7) bloodletting on haemorheology in chloasma patients with Gan (Liver) depression pattern. A total of 180 chloasma patients were randomly assigned to three groups
60 cases in each. Patients in the earacupuncture (EA) group were treated with ear-acupoint pressing combined with Ear Apex (HX6
7) bloodletting; vitamins C and E were put into practice in the Western medicine (WM) group together with 0.025% tretinoin cream for local external application; patients in the placebo group were treated with urea-cream by external use
while 30 healthy volunteers were in the control group. After a treatment course of 2 months
the changes of haemorheology
injury skin area
colour score and symptom score before and after the treatment were observed. There was no significant difference on whole blood reduced viscosity (high shear
medium shear
and low shear)
erythrocyte aggregation index
hematocrit
plasma viscosity among the four groups (F =2.65
P>0.05). Compared with those before treatment
the whole blood viscosity (high shear) and whole blood reduced viscosity (high shear) after treatment in the EA group
the WM group and the placebo group were with no statistical significance (P>0.05). The injury skin area and colour score after treatment were significantly lower than those before treatment in the EA group and the WM group (P<0.05)
while there was no significant difference in placebo group (P>0.05). Clinical symptoms of the EA group were obviously improved after the 2-month treatment
which was significantly different compared with those before treatment (P<0.05)
there was significant difference compared with those of WM group and placebo group (P<0.05). There was no significant difference on haemorheology index between healthy people and chloasma patients without angionosis
cerebrovascular disease
hematopathy
metabolic disease or any other organic disease. Ear-acupoint pressing combined with Ear Apex (HX6
7) bloodletting can effectively improve concurrent symptoms
lighten chloasma and lower chloasma area in patients accompanied by Gan depression.
chloasmaGan depressionear-acupoint pressing combined with Ear Apex (HX67) bloodlettinghaemorheology
chloasmaGan depressionear-acupoint pressing combined with Ear Apex (HX67) bloodlettinghaemorheology
Yu S, Yang FZ, Ma L. Dermatology and cosmetology. 1st ed. Beijing: Chinese Medicine Science and Technology Press; 1997:278–279.
Shi HF, Xu B, Guo XC, Qiu XW, Zhang YP, Ding XJ. Effect of Gan-Pi regulatory needling in treating chloasma. Chin J Integr Med 2010;16:66–70.
Chromatopsia Group, Committee of Chinese Association of Integrative Medicine of Dermatovenereology. Clinical diagnosis and efficacy standard of chloasma. Chin J Dermatovenereal (Chin) 2004;18:278.
Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinese medicine. 2nd ed. Beijing: Chinese Medicine Science and Technology Press; 2002:361–388.
Wang HT, ed. Cosmetology of traditional Chinese medicine. 1st ed. Beijing: China Press of Traditional Chinese Medicine; 1997:39–40.
Cui ZJ, Cen Y. Status of research of chloasma. Sichuan Med J (Chin) 2004;25:116–118.
Zhang LP. Research advancement on etiology of cloasma. J Fujian Coll Tradit Chin Med (Chin) 2001;11:61–62.
Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol 1993;129:415–421.
Lu LH, Xu C, Li N. Professor Yang Jianbing’s experience in treating female’s chloasma faciei. Modern Tradit Chin Med (Chin) 2006;26:3–4.
Wang BC. Treatment on chloasma faciei from liver. Chin J Inform Tradit Chin Med (Chin) 2000;7:69.
Xiang YP, Ou YH. Talk about the relationships of psychic factors, neuropeptide and chloasma. Chin J Inform Tradit Chin Med (Chin) 2003;10:37–38.
Xia L, Min ZS. Advancement of treatment of traditional Chinese medicine and research on cloasma. Modern J Integr Tradit Chin West Med (Chin) 2005;14:1110–1111.
Xu CK, Chu FJ. The mechanism and syndrome differentiation of chloasma. J Liaoning Univ Tradit Chin Med (Chin) 2008;10:30–31.
Shi HF, Xu B. Clinical observation on the treatment of chloasma by Chinese herbs combined with acupuncture. Chin J Integr Med 2007;13:219–223.
Lin XY, Zhou GP, Li L. A preliminary analysis of serum enzymes and haemorheology for chloasma in female patients. J Clin Dermatol (Chin) 1997;26: 359–361.
Yan M, Qin ML, Xiao L. Haemorheology of cloasma. J Clin Dermatol (Chin) 1992;21:95.
Wang P. Skills of traditional Chinese medicine: ear-acupoint pressing. 1st ed. Tianjin: Tianjin Medicine Science and Technology Press; 1999:13.
Xing HY, Jin YJ, Zhu WY, Ma L, Li HM. Study on mechanism of hemorheological and cell ularheological property in hyperlipidemia. Chin J Microcircul (Chin) 2001;11:27–29.
0
浏览量
10
Downloads
4
CSCD
关联资源
相关文章
相关作者
相关机构